Evidence map›Paper›PMID 22693455›Full record

ArticlePLoS genetics2012

Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases.

John R B Perry, Benjamin F Voight, Loïc Yengo, Najaf Amin, Josée Dupuis, Martha Ganser, Harald Grallert, Pau Navarro, Man Li, Lu Qi and 68 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02783469 (Genetics of Diabetes Audit and Research in Tayside Scotland), which is not on this map. Cited by 125 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 5 pooled it
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02783469 completednot on this map

Genetics of Diabetes Audit and Research in Tayside Scotland (DOLORisk Dundee)

TypeobservationalSponsorUniversity of DundeeRan2004 to 2009Enrolled1,915ConditionsDiabetic Neuropathic PainArmsIdentification of genetic causes of diabetic neuropathic pain
3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 5 syntheses or guidelines pooled it, 267 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Genetic comorbidities in Parkinson's disease.Human molecular genetics · 2014
    Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Maternal Age at Menarche Genes Determines Fetal Growth Restriction Risk.International journal of molecular sciences · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

78 authors at 20 institutions in 12 countries.

John R B PerryGenetics of Complex Traits, Peninsula Medical School, University of Exeter, Exeter, United Kingdom.
Benjamin F Voight
Loïc Yengo
Najaf Amin
Josée Dupuis
Martha Ganser
Harald Grallert
Pau Navarro
Man Li
Lu Qi
Valgerdur Steinthorsdottir
Robert A Scott
Peter Almgren
Dan E Arking
Yurii Aulchenko
Beverley Balkau
Rafn Benediktsson
Richard N Bergman
Eric Boerwinkle
Lori Bonnycastle
Noël P Burtt
Harry Campbell
Guillaume Charpentier
Francis S Collins
Christian Gieger
Todd Green
Samy Hadjadj
Andrew T Hattersley
Christian Herder
Albert Hofman
Andrew D Johnson
Anna Kottgen
Peter Kraft
Yann Labrune
Claudia Langenberg
Alisa K Manning
Karen L Mohlke
Andrew P Morris
Ben Oostra
James Pankow
Ann-Kristin Petersen
Peter P Pramstaller
Inga Prokopenko
Wolfgang Rathmann
William Rayner
Michael Roden
Igor Rudan
Denis Rybin
Laura J Scott
Gunnar Sigurdsson
Rob Sladek
Gudmar Thorleifsson
Unnur Thorsteinsdottir
Jaakko Tuomilehto
Andre G Uitterlinden
Sidonie Vivequin
Michael N Weedon
Alan F Wright
MAGIC
DIAGRAM Consortium
GIANT Consortium
Frank B Hu
Thomas Illig
Linda Kao
James B Meigs
James F Wilson
Kari Stefansson
Cornelia van Duijn
David Altschuler
Andrew D Morris
Michael Boehnke
Mark I McCarthy
Philippe Froguel
Colin N A Palmer
Nicholas J Wareham
Leif Groop
Timothy M Frayling
Stéphane Cauchi
Centre National de la Recherche Scientifique · FRCentre for Human Genetics · GBHarvard University · USBroad Institute · USdeCODE Genetics (Iceland) · ISErasmus MC · NLJohns Hopkins University · USBoston University · USHelmholtz Zentrum München · DELund University · SEDeutsches Diabetes-Zentrum e.V. · DEInserm · FRInstitute of Genetics and Cancer · GBMRC Epidemiology Unit · GBNational Institutes of Health · USReykjavík University · ISUniversity of Edinburgh · GBUniversity of Exeter · GBUniversity of Michigan · USCedars-Sinai Medical Center · US

Funding

Subject CollectionU10AA008401 · NIAAA · SUNY DOWNSTATE MEDICAL CENTER · PI JESSICA E SALVATORE · 1989 to 2026
$162.7M
Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
Genetic analysis of type II diabetes in Finnish populationZIAHG000024 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI ERDOS, MICHAEL · 2009 to 2025
$38.2M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTSR01CA063464 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2001 to 2005
$23.2M
Multiethnic Cohort Study of Diet and CancerR37CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 2003 to 2012
$23.2M
Genome-Wide Association Analysis in Essential Hypertension (FEHGAS study)R01HL086694 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ARAVINDA CHAKRAVARTI · 2007 to 2026
$21.2M
The Collaborative Genetic Study of Nicotine DependenceP01CA089392 · NCI · WASHINGTON UNIVERSITY · PI RICE, JOHN P · 2001 to 2012
$17.3M
Epidemiology of Venous Thrombosis & Pulmonary EmbolismR01HL059367 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI TANG, WEIHONG · 1998 to 2024
$11.8M
Identifying Genes for Type 2 Diabetes: FUSIONU01DK062370 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOEHNKE, MICHAEL L, SCOTT, LAURA J. · 2009 to 2021
$11.6M
Targeted Genetic Analysis of T2D and Quantitative TraitsR01DK072193 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN L. MOHLKE · 2005 to 2026
$11.3M
CHARGE Consortium: Omics Discovery for CVD and Aging PhenotypesR01HL105756 · NHLBI · UNIVERSITY OF WASHINGTON · PI Bruce M Psaty, NICHOLAS L SMITH · 2011 to 2026
$9.5M
Chief Scientist Office CZB/4/710Intramural NIH HHS Z01 CP010200Medical Research Council G0601261Medical Research Council MC_PC_U127561128Medical Research Council MC_PC_U127592696Medical Research Council MC_U106179471Medical Research Council MC_U127561128Medical Research Council MC_U127592696NCI NIH HHS CA136792NCI NIH HHS CA54281NCI NIH HHS CA63464NCI NIH HHS P01 CA089392NCI NIH HHS P01CA089392NCI NIH HHS R01 CA054281NCI NIH HHS R01 CA063464NCI NIH HHS R37 CA054281NCI NIH HHS U01 CA063464NCI NIH HHS U01 CA136792NCRR NIH HHS UL1 RR025005NCRR NIH HHS UL1RR025005NHGRI NIH HHS U01 HG004399NHGRI NIH HHS U01HG004399NHGRI NIH HHS U01 HG004402NHGRI NIH HHS U01HG004402NHGRI NIH HHS U01 HG004415NHGRI NIH HHS U01HG004415NHGRI NIH HHS U01 HG004422NHGRI NIH HHS U01HG004422NHGRI NIH HHS U01 HG004423NHGRI NIH HHS U01HG004423NHGRI NIH HHS U01 HG004436NHGRI NIH HHS U01HG004436NHGRI NIH HHS U01 HG004726NHGRI NIH HHS U01HG004726NHGRI NIH HHS U01 HG004728NHGRI NIH HHS U01HG004728NHGRI NIH HHS U01 HG004729NHGRI NIH HHS U01HG004729NHGRI NIH HHS U01 HG004735NHGRI NIH HHS U01HG004735NHGRI NIH HHS U01 HG004738NHGRI NIH HHS U01HG004738NHLBI NIH HHS HHSN268201100005CNHLBI NIH HHS HHSN268201100005GNHLBI NIH HHS HHSN268201100005INHLBI NIH HHS HHSN268201100006CNHLBI NIH HHS HHSN268201100007CNHLBI NIH HHS HHSN268201100007INHLBI NIH HHS HHSN268201100008CNHLBI NIH HHS HHSN268201100008INHLBI NIH HHS HHSN268201100009CNHLBI NIH HHS HHSN268201100009INHLBI NIH HHS HHSN268201100010CNHLBI NIH HHS HHSN268201100011CNHLBI NIH HHS HHSN268201100011INHLBI NIH HHS HHSN268201100012CNHLBI NIH HHS N01 HC025195NHLBI NIH HHS N01-HC-25195NHLBI NIH HHS N02-HL-6-4278NHLBI NIH HHS R01 HL059367NHLBI NIH HHS R01 HL086694NHLBI NIH HHS R01HL086694NHLBI NIH HHS R01 HL087641NHLBI NIH HHS R01HL087641NHLBI NIH HHS R01 HL105756NHLBI NIH HHS R01HL59367NIAAA NIH HHS U10 AA008401NIAAA NIH HHS U10AA008401NIDA NIH HHS R01 DA013423NIDA NIH HHS R01DA013423NIDCR NIH HHS U01 DE018903NIDCR NIH HHS U01DE018903NIDCR NIH HHS U01 DE018993NIDCR NIH HHS U01DE018993NIDDK NIH HHS DK062370NIDDK NIH HHS DK072193NIDDK NIH HHS K24 DK080140NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK062370NIDDK NIH HHS R01 DK072193NIDDK NIH HHS R01 DK078616NIDDK NIH HHS R56 DK062370NIDDK NIH HHS U01 DK062370Wellcome Trust 064890Wellcome Trust 081682Wellcome Trust 083270/Z/07/ZWellcome Trust 090532
6 · The paper itself

Abstract

Common diseases such as type 2 diabetes are phenotypically heterogeneous. Obesity is a major risk factor for type 2 diabetes, but patients vary appreciably in body mass index. We hypothesized that the genetic predisposition to the disease may be different in lean (BMI<25 Kg/m²) compared to obese cases (BMI≥30 Kg/m²). We performed two case-control genome-wide studies using two accepted cut-offs for defining individuals as overweight or obese. We used 2,112 lean type 2 diabetes cases (BMI<25 kg/m²) or 4,123 obese cases (BMI≥30 kg/m²), and 54,412 un-stratified controls. Replication was performed in 2,881 lean cases or 8,702 obese cases, and 18,957 un-stratified controls. To assess the effects of known signals, we tested the individual and combined effects of SNPs representing 36 type 2 diabetes loci. After combining data from discovery and replication datasets, we identified two signals not previously reported in Europeans. A variant (rs8090011) in the LAMA1 gene was associated with type 2 diabetes in lean cases (P = 8.4×10⁻⁹, OR = 1.13 [95% CI 1.09-1.18]), and this association was stronger than that in obese cases (P = 0.04, OR = 1.03 [95% CI 1.00-1.06]). A variant in HMG20A--previously identified in South Asians but not Europeans--was associated with type 2 diabetes in obese cases (P = 1.3×10⁻⁸, OR = 1.11 [95% CI 1.07-1.15]), although this association was not significantly stronger than that in lean cases (P = 0.02, OR = 1.09 [95% CI 1.02-1.17]). For 36 known type 2 diabetes loci, 29 had a larger odds ratio in the lean compared to obese (binomial P = 0.0002). In the lean analysis, we observed a weighted per-risk allele OR = 1.13 [95% CI 1.10-1.17], P = 3.2×10⁻¹⁴. This was larger than the same model fitted in the obese analysis where the OR = 1.06 [95% CI 1.05-1.08], P = 2.2×10⁻¹⁶. This study provides evidence that stratification of type 2 diabetes cases by BMI may help identify additional risk variants and that lean cases may have a stronger genetic predisposition to type 2 diabetes.

Indexed as

Body Mass IndexAgedAllelesAsian PeopleCase-Control StudiesDiabetes Mellitus, Type 2FemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHigh Mobility Group ProteinsHumansLamininMaleMiddle AgedObesityPolymorphism, Single NucleotideHigh Mobility Group ProteinsHMG20A protein, humanLamininlaminin A

Identifiers

PMID22693455
PMCPMC3364960
OpenAlexW2160115185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.